Page last updated: 2024-08-25

bw 12c79 and mitomycin

bw 12c79 has been researched along with mitomycin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedford, P; Bleehen, NM; Dennis, I; Falk, SJ; Nethersell, AB; Ramsay, JR; Ward, R; Wootton, R; Workman, P1
Bleehen, NM; Dixon, AK; Falk, SJ; Miles, K; Ramsay, JR; Ward, R1
Carmichael, J; Dennis, I; Ganesan, T; Mitchell, K; Philip, PA; Rajagopalan, B; Rea, D; Stuart, NS; Taylor, DJ; Thompson, CH1
Bleehen, NM; Dennis, IF; Ramsay, JR; Workman, P1
Braybrooke, JP; Dixon, RM; Ganesan, TS; Harris, AL; Levitt, NC; Littlewood, TJ; O'Byrne, K; Propper, DJ; Rajagopalan, B; Talbot, DC; Thompson, CH1

Trials

5 trial(s) available for bw 12c79 and mitomycin

ArticleYear
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzaldehydes; Drug Evaluation; Gastrointestinal Neoplasms; Hemoglobins; Humans; Middle Aged; Mitomycin; Oxygen

1992
BW12C perturbs normal and tumour tissue oxygenation and blood flow in man.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1994, Volume: 32, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzaldehydes; Cohort Studies; Erythrocytes; Gastrointestinal Neoplasms; Hemoglobins; Humans; Hypoxia; Laser-Doppler Flowmetry; Mitomycin; Muscle, Skeletal; Oxygen; Oxygen Consumption; Oxyhemoglobins; Regional Blood Flow; Skin; Tomography, X-Ray Computed

1994
A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy.
    Cancer research, 1993, Dec-01, Volume: 53, Issue:23

    Topics: Adult; Aged; Benzaldehydes; Drug Therapy, Combination; Female; Hemoglobins; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mitomycin; Muscles; Neoplasms; Oxygen

1993
Pharmacokinetics of BW12C and mitomycin C, given in combination in a phase 1 study in patients with advanced gastrointestinal cancer.
    Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:1

    Topics: Benzaldehydes; Drug Combinations; Drug Evaluation; Gastrointestinal Neoplasms; Half-Life; Humans; Metabolic Clearance Rate; Mitomycin; Neoplasm Metastasis

1993
Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
    British journal of cancer, 2000, Volume: 82, Issue:11

    Topics: Adult; Aged; Benzaldehydes; Cell Hypoxia; Colorectal Neoplasms; Drug Synergism; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Oxygen

2000